(Q44340577)

2 December 2017

title

Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcriptase analogs: a report of 9 cases (English)

1 reference

2 December 2017

1 reference

F Bonnet

1

1 reference

2 December 2017

M Bonarek

2

1 reference

2 December 2017

A Abridj

3

1 reference

2 December 2017

P Mercié

4

1 reference

2 December 2017

M Dupon

5

1 reference

2 December 2017

M-C Gemain

6

1 reference

2 December 2017

D Malvy

7

1 reference

2 December 2017

N Bernard

8

1 reference

2 December 2017

J-L Pellegrin

9

1 reference

2 December 2017

P Morlat

10

1 reference

2 December 2017

J Beylot

11

1 reference

2 December 2017

language of work or name

French

0 references

publication date

1 January 2003

1 reference

Revue de Médecine Interne

2 December 2017

published in

1 reference

2 December 2017

volume

24

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

11-16

1 reference

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Mitochondrial toxicity of antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Metabolic acidosis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

l-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2802%2900702-6

7 January 2021

10.1016/S0248-8663(02)00702-6

Identifiers

DOI

1 reference

2 December 2017

1 reference